[Federal Register Volume 65, Number 161 (Friday, August 18, 2000)]
[Notices]
[Page 50570]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21117]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 6, 2000, and published in the Federal 
Register on April 25, 2000, (65 FR 24227), Roche Diagnostics 
Corporation, 9115 Hague Road, Indianapolis, Indiana 46250, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Phencyclidine (7471).......................  II
Benzoylecgonine (9180).....................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    Roche Diagnostics Corporation plans to manufacture small quantities 
of the above listed controlled substances for incorporation in drug of 
abuse detection kits.
    DEA has considered the factors in title 21, United States Code, 
section 823(a) and determined that the registration of Roche 
Diagnostics Corporation to manufacture the listed controlled substances 
is consistent with the public interest at this time. DEA has 
investigated Roche Diagnostics Corporation on a regular basis to ensure 
that the company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.014, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.

    Dated: August 1, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-21117 Filed 8-17-00; 8:45 am]
BILLING CODE 4410-09-M